You are here: Industry Insights > CSIR

News List

CDRI gets approval for Phase III trial of Umifenovir to treat Covid-19 pharmaceutical-technology
June 22, 2020
Central Drug Research Institute (CDRI), a constituent lab of India-based Council of Scientific and Industrial Research (CSIR), has secured approval for carrying out Phase III trial for the use of Umifenovir in the treatment of Covid-19.
CSIR’s anti-cancer drug IIIM-290 goes into clinical trial expresspharma
June 09, 2020
The clinical trial aims to assess safety, tolerability and exposure of the compound in humans along with the early efficacy indicators in pancreatic cancer patients.
AIIMS Bhopal claims good results in drug trial for COVID-19 treatment expresspharma
May 18, 2020
Mycobacterium W was used for the treatment of leprosy and CSIR has tied up with Cadila Pharmaceuticals to evaluate its effect in hospitalised COVID-19 patients.
India’s CSIR proposes testing of sepsis drug as Covid-19 vaccine pharmaceutical-technology
May 08, 2020
The Council of Scientific and Industrial Research (CSIR) in India has proposed the testing of sepsis treatment drug as a vaccine for Covid-19.
CSIR identifies top 25 drugs/drug candidates for repurposing expresspharma
May 04, 2020
Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs.
CSIR backs development of a drug for patients suffering from Gram-negative sepsis expresspharma
April 22, 2020
CSIR announced that it will initiate a randomised, blinded, two arms, active comparator-controlled clinical trial to evaluate the efficacy of the drug for reducing mortality (deaths) in critically ill COVID-19 patients.

Previous page 1 2 Next page